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Abstract
Commercial, industrial pig production requires from manufacturer, to produce a large number of fattening 
pigs per sow per year, with most rational business, smaller losses in all production stages, greater growth and 
achievement the desired ϐinal weight in the shortest possible time. To make production economically viable in the 
conditions present on most domestic commercial pig farms with regard to the accommodation and environmental 
conditions, the present technology and health status is important to allow such animal nutrition that will satisfy the 
nutritional and health requirements and allow the animals adequately respond to the physiological burdensome 
conditions of intensive production in the body and exert maximum existing genetic potential in farm conditions. 
In our study conducted on a large commercial farm, inclusion hepatoprotective preparation based on ϐlavonoids 
from plant extracts and phosphoryl choline chloride as an feed additives several signiϐicant improvements in 
production are realized: reducing mortality, increased weight gain in fattening the higher meat yield in a shorter 
time and to improve health status of fattening pigs conϐirmed through lower losses (deaths and forced to slaughter. 
In the study followed the production parameters, metabolic proϐiles of the test animals, the clinical observation of 
internal organs on the slaughter and histopathological examination of a sample of 90 fattening pigs. Based on these 
results we consider that the introduction of hepatoprotective preparation as a supplement in animal feed is fully 
justiϐied and that further research in this direction can bring great beneϐits to domestic producers of pigs.
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INTRODUCTION
Free radicals and oxidative stress are terms 
that increasingly preoccupied both human and 
veterinary medicine of the 21st century, and are 
so closely connected in antioxidants. According 
to the deϐinition of antioxidants (Britton, 1995), 
these are molecules that remove the free radicals 
created them is less harmful to the molecules 
or terminate the chain reaction caused by free 
radicals. The oxidants stress leads to excessive 
production of free radicals, which cause oxidative 
damage, cell death and tissue which consequently 
leads to a distortion of the general health status 
of the organism. The level of oxidative stress is 
the basis of a number of diseases and disorders 
in human and veterinary medicine and as a result, 
the use of antioxidants becomes more important 
because of its effect on the free radicals. When it 
comes to veterinary medicine, as well as its role 
in an intensive, farm exploitation of animals, 
preventive and curative measures which it has 
as a means of preserving the health status of 
animals in conditions of intensive exploitation 
is relatively limited to the control of infectious 
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agents. The resolution of metabolic disorders such 
factors can greatly affect the level of production 
parameters in animal production as well as its very 
economical and cost-effectiveness of paramount 
importance to a balanced diet for each species and 
animals categories in a way that through proper 
formulation and technology of food animals allow 
proper physiological processes in the body and 
thus maximum productivity in terms of genetic 
possibilities and present conditions in which they 
live and produce.
Hepatoprotectives - the importance and 
possibility of application in pig production
It is known that the liver is involved in the 
processes of the metabolism of carbohydrates, 
fats, proteins, as well as water and the salts, 
pigments, vitamins, hormones. One of the most 
important liver function is detoxiϐication and is 
related to the removal of toxic substances from 
the body. Often hepatocyte damage caused by 
various harmful substances is the result of just 
its central role in metabolism. Situated between 
gastrointestinal tract and peripheral organs, the 
liver is permanently exposed to the inϐluence 
of various substances whose metabolism can 
result in toxic intermediate compounds, which 
can cause or increase the already present liver 
damage. Many toxins that enter the body via the 
gastrointestinal tract requires a conversion from 
the insoluble to the soluble metabolites, so they 
can be excreted via the urine or bile. Drugs, a toxic 
product present in the animal feed or created in 
the body by decarboxylation of the amino acids 
from protein, under the action of bacteria in 
the intestines (histamine, tyramine, putrescine, 
cadaverine, spermine), some supplements 
(additives, emulsiϐiers, coloring agents, etc.) and 
a host of other harmful substances liver animals 
need to detoxify and remove from the body. When 
the liver is too burdened and unable to cope with 
such a quantity of hazardous substances, the cells 
of the liver are damaged, and they cannot perform 
their function. Are replaced by connective cells 
causing liver is no longer able to perform its 
primary function. Hepatoprotectives are intended 
to protect the liver from damage and normalize its 
operations after infectious, toxic, viral and other 
harmful effects. These are a variety of biologically 
active substances that protect the membrane 
of hepatocytes , normalize and improve their 
interaction and function. Flavonoids are substances 
synthesized only in plants, animals and people are 
not able to produce them yourself. Scientiϐically 
proven effects of ϐlavonoids in humans have 
protective effect on the liver, inhibition of fat 
oxidation, antiviral and antibacterial properties, 
regeneration of the skin and mucous membranes, 
and antitumor activity. The basic pharmacological 
activity of ϐlavonoids is associated with their effect 
on the wall of the blood vessels of the peripheral 
circulation. Reduce permeability and fragility, and 
increase the elasticity and tone of the main wall of 
the capillary. Effect of ϐlavonoids on the capillary 
may be explained by their ability, as a proton 
donor, to prevent the reduction of dehydroascorbic 
acid and thus protect vitamin C. Another 
explanation is that these natural polyphenols 
inhibit enzymes (hyaluronidase, elastase and 
catechol-O-methyltransferase) and slows down 
the degradation of elastin. Flavonoids are found 
application in the treatment of different diseases 
that are caused by the disorder and hepatic blood 
and lymph vessels of the peripheral circulation. 
To livers could fulϐills its main role and detoxify a 
large amount of toxic substances, a large amount 
of energy that is enough glycogen in the liver. In 
cases where there is not enough glycogen available 
when intensive detoxiϐication processes in the 
liver to accumulate fat which liver cells are trying 
to provide enough glucose. In extreme conditions, 
the content of fat in the liver can be very large with 
nastajenjem fatty degeneration of hepatocytes 
and liver function disorder itself. Phosphoryl 
choline chloride reduces the amount of fat in the 
liver helps process the glucose production, and 
thereby facilitates the process of elimination 
of toxic substances as an additional energy 
source. Phosphoryl choline chloride represents 
a biologically active substance choline chloride, 
which occurs physiologically in the liver. Adding 
external phosphorylcholine chloride, this process 
is signiϐicantly facilitates its direct involvement in 
the processes of fat metabolism in the liver. 
MATERIAL AND METHOD
On the commercial farm of 1500 sows in 
Serbia, we conducted a survey on the impact of 
the hepatoprotective preparation of the health 
status and production performance of fattening 
pigs by adding it to the standard mixture in an 
amount of 2 kg / t of food. The farm is loaded 
with the usual medical pathology of domestic 
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pig farms. Testing was performed 19/11/2013. - 
03/07/2014. 90 ϐinishing pigs were included in 
the examination, from entering into the fattening 
stable up delivery. The aim of the experiment 
was to examine the effect of the hepatoprotective 
preparation PRO-FORTE based on plant extracts 
and phosphorylcholine chloride on: General 
health of fatteners, increase the ϐinal mass 
slaughter fattening pigs, increase growth and 
reduce mortality. The experiment included 45 pigs 
in the experimental group and 45 in the control 
group. Experimental group was fed with standard 
mixture used on the farm at this stage, with the 
addition of 2 kg/t mixture PRO-FORTE made by 
Patent Co. A control group was fed the standard 
mixture used at the farm use at this stage on farm. 
 The parameters monitored in the experiment 
were: 1. The number of pigs at the beginning and 
end of the experiment; 2. Total weight of pigs 
at the beginning of the experiment; 3. Average 
weight piglets; 4. The number of fattening 
pigs at delivery (experiment and control); 5. 
Total weight at delivery; 6 Percent death; 7 
Percent emergency slaughter; 8. Total growth 
9. AverageADG-group. During the experiment, 
we followed by the metabolic proϐiles of piglets 
on the basis of biochemical parameters in the 
blood of piglets on the same sample of 40 pigs 
(20 experimental + 20 in the control group) at the 
beginning of the experiment, 60 days and 120 days. 
The parameters which were monitored are: total 
protein, albumin, total bilirubin, transaminases, 
glucose, Ca, P, creatinine, uric acid. At the end of 
the experiment was carried out inspection bodies 
porkers experimental and control groups on the 
slaughter line. Collected data on body weight 
and daily gain of fattening pigs in the experiment 
were statistically analyzed, appropriate statistical 
Fig. 1. Results of measurements of body mass of piglets, the control and experimental groups.
Fig. 2. The growth of the piglets during the experiment, the control and experimental groups. 
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methods. The obtained results were analyzed using 




Results of measurements of body mass of 
piglets, the control and experimental groups are 
shown in Fig. 1.
Results of measurements of body mass of 
piglets, the control and experimental groups are 
shown in Fig. 2
Biochemical parameters in pig blood samples 
are shown in tables 1, 2 and 3
Loos of piglets during trial (death and the 
slaughter) are showed in Table 4
List of slaughterhouse reviews lungs of 
slaughtered pigs is showed in Table 5
Patohistological examination internal organs. 
Pathohistological ϐindings of the trial group are 
presented in Figure 3a. 
Body weight: The average body weight of 
ϐinishing pigs at the beginning of the experiment 
was 22,61kg 22,41kg the experimental and the 
control group (Chart 1). Body weight of fattening 
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Tot..prot (Do 8,6 g/dl) 5,5 5,7
Glu (3,9-6,3Mmol/l) 4,6 4,7
Tot.bil (0-8,5 μmol/l) 10,5 6,9
ALP (0-176 IU/l) 109,1 105,7
ALT (21-46,5 IU/l) 53,0 56,1
AST (15-53 IU/l) 66,8 50,3
Ca (2,4-3,0 Mmol/l) 2,6 2,4
P (1,8-3 Mmol/l) 2,9 2,9
Uric acid (0-102,3 
μmol/l)
38,5 28,2











Tot.prot (Do 8,6 g/dl) 6,4 6,4
Glu (3,9-6,3Mmol/l) 3,9 3,3
Tot..bil (0-8,5 μmol/l) 5,1 4,5
ALP (0-176 IU/l) 117,5 73,2
ALT (21-46,5 IU/l) 63,8 56,6
AST (15-53 IU/l) 47,3 44,8
Ca (2,4-3,0 Mmol/l) 2,2 2,4
P (1,8-3 Mmol/l) 3,0 3,0
Uric acid (0-102,3 
μmol/l)
19,4 25,7













1 2,22 2 4,54 6,66
Experimental 
group 
1 2,17 0 0 2,17











Tot.prot (Do 8,6 g/dl) 5,4 5,8
Glu (3,9-6,3Mmol/l) 5,4 6,1
Tot.bil (0-8,5 μmol/l) 11,6 6,5
ALP (0-176 IU/l) 141,5 158,5
ALT (21-46,5 IU/l) 72,4 67,7
AST (15-53 IU/l) 102,0 80,5
Ca (2,4-3,0 Mmol/l) 2,0 2,5
P (1,8-3 Mmol/l) 3,0 3,0
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Tab. 5. List of slaughterhouse reviews lungs of slaughtered pigs: 





Apical and cardial lobes





Pneumonia catarrhalis with complications - -
Pneumonia catarrhalis disseminata (lobular.) - -
Pneumonia ϐibrinosa - -
Pneumonia ϐibrinosa partim necrotica - -
Pneumonia apostematosa disseminata - -
Pleuropneumonia acuta/ subacuta - 3
Pleuropneumonia chronica - -
Chron. Pleuritis localised - 3
Chron. pleuritis, generalisata - 1
Pericarditis serosa - -
TOTAL: 8 20
Milk stains 1 1
Fig. 3b. Pathohistological ϐindings of the control group.
1) Liver – general look, well preserved lobular structure, 
2) Liver, region of centrilobular vein appears regular, surrounding sinusoids very narrowed, bright hepatocytes, 
granular cytoplasm, 
3) Liver, hepatocytes mostly enlarged, bright granular cytoplasm, sinusoids compressed, 
4) Kidney with focal lymphocytic inϐiltrate between the tubules, 
5) Kidney, a proliferative change in one of the glomerulus.
Fig. 3a. Pathohistological ϐindings of the trial group.
1) Liver – preserved hepatocytes on the outskirts of the cross-section, 
2) Liver – centrilobular vein of regular appearance, surrounded by hepatocytes of granular cytoplasm, 
3) Kidney – preserved condition of glomerulus, 
4) Lung actinomycosis, 
5) Bronchiolitis purlenta  acuta
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pigs was the control measurement (60 days) 
62,8125kg 60,8152kg in the experimental and the 
control group which was statistically signiϐicantly 
higher (p = 0.028). At the ϐinal measurement of 
body mass ϐinishing pigs in the experimental 
group was 101,6kg a 95,642kg in the control 
group, which was statistically signiϐicantly higher 
(p = 0.001).
 Daily gain of piglets: Growth of the ϐirst and 
second measurements was the experimental group 
0.628 kg / day, which was statistically signiϐicantly 
higher (p = 0.007) of 0.589 kg / day, what was the 
increase in the control group. Gain from the second 
to the third measurement was in the experimental 
group 0,878 kg / day, which was signiϐicantly 
higher (p = 0.011) of 0.807 kg / day, what was the 
increase in the control group. The total increase 
in the experiment in the experimental group was 
0.731 kg / day, which was statistically signiϐicantly 
higher (p = 0.000) compared to the control group, 
in which the gain was 0.678 kg / day (Chart 2).
Losses of piglets: During the trial total losses 
of piglets (death and forced to slaughter) in the 
experimental group was 6.66% compared to the 
control which were 2.17% (Table 4). Biochemical 
indicators: 1. creatinine concentration in the 
experimental group showed a tendency to increase, 
which can be interpreted in proportion to the 
increase in muscle mass and metabolic activities 
designed. Creatinine can also be increased in the 
experimental group due to lack of food (degraded 
their muscles that make up proteins), poor blood 
supply to the kidneys due to low blood pressure, 
haemoconcentration, increased physical activity. 
2 ALP in the experimental group increased in 
the second and third measurement, because 
there is increased activity of bone metabolism. 
Due to the increased growth of the experimental 
group, Ca does not have enough available to 
support increased growth and weight gain of the 
experimental group. In contrast to the control 
group in which the Ca is the physiological fairness 
in all three measurements. Due to the mobilization 
of Ca from depots in the bones, ALP is therefore 
increased. Do not view this group was to increase 
the provision of Ca in the diet and thus support 
growth even better. Uric acid in the experimental 
group during the second measurement showed 
an increase in concentration. The secondary may 
occur in the degradation of proteins due to their 
own lack of food. The fact that the experimental 
group had greater weight gain compared to 
control. If we take into account that received the 
same amount of food in the experimental group 
was markedly following: 
- Increased creatinine as a result of the degradation 
of its own protein ;
- Increased uric acid secondary to protein catabo-
lism;
- Increased ALP primarily due to insufϐicient 
intake of calcium and mobilization of Ca from 
the bones for growth.
Transaminases, despite the expected showed 
no signiϐicant difference between the groups, 
which was conϐirmed by histopathological ϐindings. 
Positive impact of hepatoprotective additive 
was conϐirmed on the level of metabolism and 
increased weight gain in the experimental group. 
Slaughter examination of internal organs slaughter 
examination of organs of slaughtered fattening 
pigs were observed striking macroscopic changes 
in the livers and kidneys in the control than in 
the experimental group. The lungs of slaughtered 
fattening pigs distinct histological changes 
were observed in 20 fattening pigs (47.61%) 
in the control and 8 ϐinishing pigs (18%) in the 
experimental group. 
CONCLUSION
Based on the above it can be concluded 
that the application of the preparation Proforte 
as an supplement in the diet of fattening pigs 
achieved signiϐicant improvement in production 
parameters investigated pig, achieved a positive 
effect on health, reduced losses to the favorable 
ϐinancial effect   
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